Sara V. Latorre

Quick facts

Phase 2 pipeline

• ARI-0001 cells · Oncology
  ARI-0001 cells are a type of immunotherapy that stimulate the immune system to attack cancer cells.

Phase 1 pipeline

• Adult differentiated autologous T-cells

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sara V. Latorre portfolio CI brief
• Sara V. Latorre pipeline updates RSS